When does HEMOSTEMIX INC (HEM.CA) report earnings?
HEMOSTEMIX INC (HEM.CA) will report earnings on 2026-04-27.
HEMOSTEMIX INC (HEM.CA) Forecast, Price Target & Analyst Ratings
TSX-V:HEM • CA4236943060
Current stock price
0.065 CAD
-0.01 (-7.14%)
Last:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for HEMOSTEMIX INC (HEM.CA).
Forecast Snapshot
Price Target Details & History
Consensus Price Target and Range
Mean target
N/A
Upside
N/A
From current price of CA$0.07 to mean target of N/A, Based on 9 analyst forecasts
Low
N/A
Median
N/A
High
N/A
Price Target Revisions
1 Month
0.00%
3 Months
0.00%
Price Target Summary
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
84.44%
HEM.CA was analyzed by 9 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about HEM.CA.
In the previous month the buy percentage consensus was at a similar level.
HEM.CA was analyzed by 9 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2022-08-30 | Fundamental Research | Initiate | Buy |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- Apr 27, 2026
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A
Next Earnings Summary
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | |||||||||||
| EBITDA YoY % growth | -3.945M | N/A | N/A | N/A | -4.695M | -7.464M -58.99% | -6.655M 10.84% | -4.578M 31.21% | -2.157M 52.88% | -1.979M 8.26% | |
| EBIT YoY % growth | -3.982M | -2.614M 34.35% | -2.81M -7.51% | -6.423M -128.56% | -4.696M 26.89% | -7.466M -58.99% | -6.656M 10.86% | -4.578M 31.22% | -2.157M 52.88% | -1.979M 8.27% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A -40.00% | N/A |
All data in CAD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in CAD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
N/A
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
HEMOSTEMIX INC / HEM.CA Forecast FAQ
How many analysts cover HEMOSTEMIX INC (HEM.CA) stock?
The number of analysts covering HEMOSTEMIX INC (HEM.CA) is 9.